Sludge-Fertilizer Giant Leaves Texas Town Amid ‘Forever Chemicals' Crisis
The City of Fort Worth, Texas, is ending its contract with Synagro, the Goldman Sachs-backed provider of fertilizer made from sewage sludge, over concerns that 'forever chemicals' in the fertilizer are contaminating local farmland and groundwater.
Fort Worth this month also sued several manufacturers of the chemicals, also called per- and polyfluoroalkyl substances or PFAS, alleging that they contaminated the city's water supplies.
The New York Times reported last year on a group of ranchers in Johnson County, just south of Fort Worth, who sued Synagro, blaming the fertilizer used on neighboring farmland for contaminating their crops and livestock.
The sewage-sludge fertilizer came from Synagro, which had a contract to take sewage from Fort Worth's sewage treatment plant, treat it further, and distribute it to farmers as fertilizer. Johnson County has since launched a criminal investigation into Synagro.
A growing body of research has shown that sewage sludge, much of which is used as fertilizer, can be contaminated with PFAS, a synthetic chemical used widely in everyday items like nonstick cookware and stain-resistant carpets.
The chemicals, which are linked to a range of illnesses including an increased risk of cancer, do not break down in the environment. When tainted sludge is used as fertilizer on farmland, it can contaminate the soil, groundwater, crops and livestock.
In January, the Environmental Protection Agency warned for the first time that PFAS present in sewage fertilizer, also known as biosolids, can pose human health risks. Maine, the only state that has started to systematically test farmland for PFAS, has detected the chemicals at dozens of dairy farms. But there has been little testing on farms in other states.
Fort Worth's city council voted unanimously on Tuesday to cancel a 10-year contract signed with Synagro in 2019. The contract will end on April 1, and staff at the city's water utility are working on new contracts for its biosolids operations, according to council records.
The city did not cite a reason for terminating the contract. But in a recent lawsuit filed by Fort Worth against the manufacturers of PFAS chemicals, the city cited the presence of PFAS in the city's drinking-water sources and wastewater infrastructure.
Synagro said in a statement that the company and the city of Fort Worth 'mutually agreed to part ways and settle all claims following ongoing disagreements regarding contract requirements.' It said that the termination was unrelated to PFAS. The city's water department did not immediately respond to a request for comment.
Synagro, owned by Goldman Sachs Asset Management, has disputed claims that its biosolids have contaminated Texas farmland. This month, the company filed a motion to dismiss the Johnson County ranchers' claims, citing an independent investigation it had commissioned that concluded that sludge fertilizer could not be the source of high PFAS levels found in the ranchers' livestock.
Synagro also said testing had shown far lower levels of PFAS in the soil than claimed by the ranchers. The company has not publicly released the investigation.
Lawyers representing the ranches could not be reached for comment. The ranchers have stopped sending their cattle to market, while continuing to care for them, and say they face financial ruin.
Dana Ames, an environmental investigator leading Johnson County's probe of Synagro, said an 'exhaustive investigation' had found high levels of PFAS on the rancher's property. 'We have ruled out all other sources of contamination. We also tested the biosolids and found contamination,' she said.
At the council meeting, Luanne Langley, a resident of Grandview, Texas, accused the city of standing by while Synagro 'dumped biosolids on unsuspecting landowners and farmers.' She said canceling the contract was not enough. 'How is that going to help the families whose lives have been destroyed?' she said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
31 minutes ago
- Yahoo
City of Spokane releases its 2024 report on drinking water quality
Jun. 10—The city of Spokane met all state and federal drinking water standards last year, according to its required 2024 report on drinking water quality measuring levels of contaminants and "forever" chemicals in its source wells. PFAS, also known as polyfluoroalkyl substances, refers to a group of human-made chemicals that has been used in consumer products since the 1950s. Think nonstick cookware, water-resistant fabrics, certain cleaning products or fire-fighting foam. Exposure to high levels of these chemicals has been linked to detrimental health effects, including decreased fertility, developmental delays and a higher risk of some type of cancers, such as kidney and prostate cancer. The components of these substances usually take hundreds or thousands of years to break down, and their widespread use has resulted in their prevalence everywhere — including in our drinking water. Washington established state action levels in 2022 to address PFAS, providing thresholds for the amount of contamination drinking water can contain before specific state actions must take place. In April 2024, the EPA announced a new federal standard: a maximum containment level of 4 parts per trillion of PFAS. Although the EPA requires water purveyors to meet this federal regulatory standard by 2027, the city has already updated its testing and monitoring procedures to account for the contaminants. "We're all kind of learning together," public works communications manager Kirstin Davis said. "Some of the prior standards didn't have as complicated and as detailed of testing as what's available now." The city of Spokane detected low levels of PFAs in three well locations: Havana Well, Nevada Well and Ray Street Well. During a test in February, the Ray Street Well measured slightly above the federal standard at 6.1 parts per trillion of PFOS, a specific type of PFA. EPA rules, however, measure compliances based on a four-quarter rolling average of test results. Further testing of that well in June and October resulted in lower levels of PFAs detected, making the average just below the federal limit. The report also analyzed other levels of inorganic chemicals and found traces of arsenic, barium, lead, copper, nitrate and radionuclides in the source wells, all below the federal limit. This year's Spokane City Water Quality report is accessible on the City's water quality webpage.
CBS News
7 hours ago
- CBS News
"Forever chemicals" found in fish caught in San Francisco Bay, report warns
A warning to anglers who eat their catch from the San Francisco Bay, fish pulled from the waters may contain dangerous levels of so-called "forever chemicals." In a recent report by the San Francisco Estuary Institute, scientists detected 20 types of polyfluoroalkyl substances, known as PFAS in fish caught in the bay. Their research and testing of fish began in 2009, and a revised study was published in the American Chemical Society this past March. "PFAS have been known to harm us in a variety of different ways, they've been known to cause cancer," said Miguel Mendez, the lead author of the SFEI study. "It affects us in variety of different organs, including the liver, and over time can cause some severe health effects." Along the docks of San Francisco's Embarcadero, one will find a variety of fisherman who are there for sport or relaxation, but a number of people fish the docks for food. "I think for communities, especially those that are eating every day from the Bay, that is a huge concern and likely leading to a higher load of PFAS and other contaminants, for these populations," said Mendez. Along Pier One, longtime anglers Danny Tran and Nick Hayden were posted up on a sunny afternoon, and both say while they love to fish, they are careful about how much of their catch they consume. "I don't eat too much fish, so I'm okay with it," said Tran. "I probably eat once a month, twice a month and that's about it." "You have to choose what you eat, the smaller (younger) the better, because there's less chemicals in them," said Hayden. "The bigger ones have higher levels of mercury, or whatever they have inside of them." Currently there are no specific state guidelines on the consumption of fish in relation to PFAS. But since 2011 the California Office of Environmental Health Hazard Assessments has offered recommendations on 18 fish species on which types of fish to avoid, which fish are safe to eat, and how many servings are recommended per week, along with gender and age advisories. They updated their recommendations in April of 2023, and have posted signs along local docks. Where anglers catch their fish, can also determine the level of "forever chemicals." SFEI conducted tests in 12 different locations and found higher levels of PFAS in the South Bay. "The South Bay is a hotspot for PFAS, but that doesn't mean that the North Bay is the immune or doesn't have PFAS at all, because fish can swim for location to location," said Mendez. "To those who may have a seafood heavy diet, you should really think about where is my seafood coming from."
Miami Herald
8 hours ago
- Miami Herald
Domino's Pizza, McDonald's rating surprise tied to persistent consumer issue
Even the Hamburglar didn't see this one coming. Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living with obesity, according to the Centers for Disease Control and Prevention. Don't miss the move: Subscribe to TheStreet's free daily newsletter As obesity rates have risen, so have scientists' efforts to address this serious health issue, which can cause asthma, heart disease, stroke, type 2 diabetes and even some cancers. Early attempts to treat obesity came to the market as early as the 1930s. Amphetamines were the prevalent treatment in the 1940s and 1950s and demand continued into the 1990s. Glucagon-like peptide-1 agonists, which mimic the action of the naturally occurring hormone GLP-1, have been available for about two decades. GLP-1 medications, including Ozempic, Wegovy, Zepbound and Mounjaro, have been used for years to treat Type 2 diabetes, and studies have found that they are also effective at encouraging weight loss. Wegovy and Ozempic are manufactured by Novo Nordisk (NVO) , while Eli Lilly (LLY) makes Zepbound and Mounjaro. Image source:One investment firm says increased use of these medications could have serious implications for two of the biggest names in the fast-food industry: McDonald's (MCD) and Domino's Pizza (DPZ) . The market for anti-obesity drugs, particularly those using injectable versions of GLP 1-based drugs, is still new and continuously evolving, Goldman Sachs said in a May 22 report. More Restaurants Beloved Mexican restaurant closing iconic location after 63 yearsMajor restaurant chain quietly closes several locationsIconic restaurant closing its doors after 32 years The investment firm lowered its projections for such medication and now forecasts the global market to reach $95 billion by 2030. That's down from the previous estimate of $130 billion to reflect trends influencing how the drugs are priced, how long patients stay on them, and how patient populations are segmented. Goldman lowered its U.S. market projections to a peak of $70 billion, but the firm sees room for greater penetration in markets outside the U.S. Goldman forecasts a market peak of $50 billion outside the US, compared with $35 billion previously. A survey of more than 50 doctors in the US found that lower doses of anti-obesity medications are working well for a majority of patients and insurance coverage is the most important factor in the decision-making process, Goldman Sachs wrote. "But to be clear, even with this moderated forecast, we see a significant growth opportunity for both existing players as well as new entrants into this market," said Asad Haider, head of the health-care business unit within Goldman Sachs Research. Demand for GPL-1 drugs could dramatically hinder the food and restaurant industries, according to a study from Cornell's SC Johnson College of Business and the data firm Numerator. The report, entitled "The No Hunger Games," found that households with at least one user of GLP-1 drugs reduced its grocery spending by about 6% within six months of starting the drugs. The spending cut was as much as 9% for higher-income households. "We also find an 8.6% decline in spending at fast-food chains, coffee shops and limited-service restaurants," the study said. "Our findings highlight the potential for GLP-1 medications to significantly change food demand, a trend with increasingly important implications for the food industry as GLP-1 adoption continues to grow." The study warned that common side effects of GLP-1 medications, such as nausea, vomiting and gastrointestinal discomfort, have reportedly led to reduced adherence or discontinued use for some patients. Related: McDonald's analyst grills new stock price target on McCrispy reaction "Moreover, their long-term efficacy and safety remain areas of ongoing investigation," the report said. Redburn Atlantic analyst Chris Luyckx focused on the growing adoption of GLP-1 in recent research reports. Luyckx double-downgraded McDonald's to sell from buy with a price target of $260, down from $319. The analyst expects the GLP-1 weight-loss drugs to suppress consumer appetites and says they present an underappreciated longer-term threat for McDonald's. A 1% drag on sales today "could easily build to 10% or more over time," particularly for restaurant brands skewed toward lower-income consumers, the analyst tells investors in a research note. McDonald's stock was down about 1.3% at last check and is up 18.5% from a year ago. Redburn Atlantic also initiated coverage of Domino's Pizza with a sell rating and $340 price target. Domino's, the world's largest pizza chain, faces the heaviest pressure from adoption of GLP-1 weight loss drugs, with high exposure to dinner occasions and lower-income consumers, the firm said. Redburn Atlantic said the company's organic traffic remains weak, with carry-out far outpacing delivery. Challenged system-sales growth and elevated consensus expectations present downside risk for Domino's, the firm said. McDonald's closed regular trading on June 10 down 1.4% at $300.43. Domino's shares were off 2.7% at $455.49. Related: Fund-management veteran skips emotion in investment strategy The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.
